Rituximab for the Treatment of Isolated Refractory Desquamative Gingivitis Due to Mucous Membrane Pemphigoid

JAMA Dermatol. 2016 Dec 1;152(12):1396-1398. doi: 10.1001/jamadermatol.2016.3434.

Authors

Stefanie Haefliger¹, Michael P Horn², Valerie G A Suter³, Michael M Bornstein³, Luca Borradori¹

Affiliations

¹ Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
² University Institute of Clinical Chemistry and Center of Laboratory Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
³ Department of Oral Surgery and Stomatology, School of Dental Medicine, University of Bern, Bern, Switzerland.

PMID: 27732708
DOI: 10.1001/jamadermatol.2016.3434

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Diagnosis, Differential
Dose-Response Relationship, Drug
Female
Gingivitis / diagnosis
Gingivitis / drug therapy*
Gingivitis / etiology
Humans
Immunologic Factors / administration & dosage
Male
Middle Aged
Mucous Membrane / pathology
Pemphigoid, Benign Mucous Membrane / complications
Pemphigoid, Benign Mucous Membrane / diagnosis
Pemphigoid, Benign Mucous Membrane / drug therapy*
Remission Induction
Rituximab / administration & dosage*

Substances

Immunologic Factors
Rituximab